• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Eculizumab as rescue therapy in severe resistant lupus nephritis.

作者信息

Pickering Matthew C, Ismajli Mediola, Condon Marie B, McKenna Nicola, Hall Angela E, Lightstone Liz, Terence Cook H, Cairns Thomas D

机构信息

Imperial College NHS Healthcare Trust Lupus Centre and

Imperial College NHS Healthcare Trust Lupus Centre and.

出版信息

Rheumatology (Oxford). 2015 Dec;54(12):2286-8. doi: 10.1093/rheumatology/kev307. Epub 2015 Aug 27.

DOI:10.1093/rheumatology/kev307
PMID:26316577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4643725/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a352/4643725/ea4651e3a5d3/kev307f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a352/4643725/ea4651e3a5d3/kev307f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a352/4643725/ea4651e3a5d3/kev307f1p.jpg

相似文献

1
Eculizumab as rescue therapy in severe resistant lupus nephritis.依库珠单抗作为重症难治性狼疮性肾炎的挽救疗法。
Rheumatology (Oxford). 2015 Dec;54(12):2286-8. doi: 10.1093/rheumatology/kev307. Epub 2015 Aug 27.
2
[Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy].[依库珠单抗作为狼疮性肾炎相关血栓性微血管病的挽救治疗]
G Ital Nefrol. 2020 Jun 10;37(3):2020-vol3.
3
Rituximab-refractory lupus nephritis successfully treated with belimumab.贝利尤单抗成功治疗利妥昔单抗难治性狼疮性肾炎。
Clin Exp Rheumatol. 2016 Mar-Apr;34(2):355-6. Epub 2016 Feb 9.
4
BLISS in the Treatment of Lupus Nephritis.BLISS用于狼疮性肾炎的治疗。
Clin J Am Soc Nephrol. 2021 Jun;16(6):969-971. doi: 10.2215/CJN.17991120. Epub 2021 Feb 3.
5
Belimumab may not prevent lupus nephritis in serologically active patients with ongoing non-renal disease activity.贝利尤单抗可能无法预防血清学活跃且伴有持续非肾脏疾病活动的患者发生狼疮性肾炎。
Scand J Rheumatol. 2014;43(5):428-30. doi: 10.3109/03009742.2014.887769. Epub 2014 Apr 2.
6
Case report: successful treatment of membranous lupus nephritis with belimumab in an African female immigrant.病例报告：贝利尤单抗成功治疗一名非洲女性移民的膜性狼疮性肾炎
Clin Rheumatol. 2016 Jun;35(6):1649-53. doi: 10.1007/s10067-015-3153-1. Epub 2015 Dec 28.
7
Eculizumab and refractory membranoproliferative glomerulonephritis.依库珠单抗与难治性膜增生性肾小球肾炎
N Engl J Med. 2012 Mar 22;366(12):1165-6. doi: 10.1056/NEJMc1106619.
8
Eculizumab treatment for rescue of renal function in IgA nephropathy.依库珠单抗治疗IgA肾病以挽救肾功能
Pediatr Nephrol. 2014 Nov;29(11):2225-8. doi: 10.1007/s00467-014-2863-y. Epub 2014 Jun 13.
9
Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman.成功治疗 19 岁女性吗替麦考酚酯难治性增生性狼疮肾炎：贝鲁单抗的应用。
Lupus. 2013 Dec;22(14):1523-5. doi: 10.1177/0961203313504145. Epub 2013 Sep 6.
10
Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy.依库珠单抗对一名常规治疗耐药的弥漫性增殖性狼疮性肾炎患儿产生显著疗效。
Pediatr Nephrol. 2015 Jan;30(1):167-72. doi: 10.1007/s00467-014-2944-y. Epub 2014 Aug 31.

引用本文的文献

1
The Crosstalk Between NETs and the Complement Cascade: An Overview in Nephrological Autoimmune Disease.中性粒细胞胞外陷阱与补体级联反应之间的相互作用：肾脏自身免疫性疾病概述
Int J Mol Sci. 2025 Mar 20;26(6):2789. doi: 10.3390/ijms26062789.
2
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics.系统性红斑狼疮：关于发病机制、诊断、预防及治疗的最新见解
Signal Transduct Target Ther. 2025 Mar 17;10(1):102. doi: 10.1038/s41392-025-02168-0.
3
Systemic lupus erythematosus presenting with atypical hemolytic uremic syndrome: a case report and review of the literature.

本文引用的文献

1
Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy.依库珠单抗对一名常规治疗耐药的弥漫性增殖性狼疮性肾炎患儿产生显著疗效。
Pediatr Nephrol. 2015 Jan;30(1):167-72. doi: 10.1007/s00467-014-2944-y. Epub 2014 Aug 31.
2
Eculizumab treatment for rescue of renal function in IgA nephropathy.依库珠单抗治疗IgA肾病以挽救肾功能
Pediatr Nephrol. 2014 Nov;29(11):2225-8. doi: 10.1007/s00467-014-2863-y. Epub 2014 Jun 13.
3
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
以非典型溶血尿毒综合征为表现的系统性红斑狼疮：病例报告及文献复习。
Rheumatol Int. 2024 Oct;44(10):2213-2225. doi: 10.1007/s00296-024-05558-9. Epub 2024 Mar 19.
4
Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies.免疫介导性坏死性肌病（IMNM）：抗体的故事
Antibodies (Basel). 2024 Feb 7;13(1):12. doi: 10.3390/antib13010012.
5
Immune podocytes in the immune microenvironment of lupus nephritis (Review).狼疮肾炎免疫微环境中的免疫足细胞（综述）。
Mol Med Rep. 2023 Nov;28(5). doi: 10.3892/mmr.2023.13091. Epub 2023 Sep 15.
6
Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN).狼疮性肾炎的诊断与治疗：西班牙肾小球疾病研究组（GLOSEN）共识文件总结
Clin Kidney J. 2023 Mar 22;16(9):1384-1402. doi: 10.1093/ckj/sfad055. eCollection 2023 Sep.
7
Complement therapeutics are coming of age in rheumatology.在风湿病学中，补充疗法正在走向成熟。
Nat Rev Rheumatol. 2023 Aug;19(8):470-485. doi: 10.1038/s41584-023-00981-x. Epub 2023 Jun 19.
8
Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren's syndrome: evidence- and practice-based guidance.系统性红斑狼疮、抗磷脂综合征和干燥综合征的生物治疗：基于证据和实践的指南。
Front Immunol. 2023 Apr 17;14:1117699. doi: 10.3389/fimmu.2023.1117699. eCollection 2023.
9
Case report: Thrombotic microangiopathy concomitant with macrophage activation syndrome in systemic lupus erythematosus refractory to conventional treatment successfully treated with eculizumab.病例报告：血栓性微血管病合并巨噬细胞活化综合征，在常规治疗无效的系统性红斑狼疮患者中，使用依库珠单抗成功治疗。
Front Med (Lausanne). 2023 Jan 9;9:1097528. doi: 10.3389/fmed.2022.1097528. eCollection 2022.
10
Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model.在人源化小鼠模型中通过C5补体抑制预防抗HMGCR免疫介导的坏死性肌病
Biomedicines. 2022 Aug 20;10(8):2036. doi: 10.3390/biomedicines10082036.
前瞻性观察性单中心队列研究评估利妥昔单抗联合霉酚酸酯治疗狼疮性肾炎而不使用口服皮质类固醇的疗效。
Ann Rheum Dis. 2013 Aug;72(8):1280-6. doi: 10.1136/annrheumdis-2012-202844. Epub 2013 Jun 5.
4
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.依库珠单抗治疗非典型溶血尿毒综合征。
N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981.
5
Targeting the complement system in systemic lupus erythematosus and other diseases.靶向系统性红斑狼疮和其他疾病中的补体系统。
Clin Immunol. 2013 Sep;148(3):313-21. doi: 10.1016/j.clim.2013.02.014. Epub 2013 Mar 5.
6
Eculizumab for dense deposit disease and C3 glomerulonephritis.依库珠单抗治疗致密物沉积病和 C3 肾小球肾炎。
Clin J Am Soc Nephrol. 2012 May;7(5):748-56. doi: 10.2215/CJN.12901211. Epub 2012 Mar 8.
7
Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.依库珠单抗对阵发性夜间血红蛋白尿患者溶血及输血需求的影响。
N Engl J Med. 2004 Feb 5;350(6):552-9. doi: 10.1056/NEJMoa031688.
8
Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.用针对补体成分C5的阻断性单克隆抗体治疗后，NZB/WF1小鼠狼疮样自身免疫病得到改善。
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8563-8. doi: 10.1073/pnas.93.16.8563.